Fatty acid synthase (FASN) as a therapeutic target in breast cancer.
作者： Javier A. Menendez , Ruth Lupu
DOI: 10.1080/14728222.2017.1381087
关键词:
摘要: … nature of fatty acid synthase (FASN) in breast cancer. … FASN is intertwined with various signaling networks to cell-autonomously regulate breast cancer initiation and progression, FASN …
elsevier.com
sci-hub.se 参考文章(209)
Gil Ma, Manuel Zancanella, Yatsandra Oyola, Robyn D. Richardson, Jeffrey W. Smith, Daniel Romo, Total Synthesis and Comparative Analysis of Orlistat, Valilactone, and a Transposed Orlistat Derivative: Inhibitors of Fatty Acid Synthase Organic Letters. ,vol. 8, pp. 4497- 4500 ,(2006) , 10.1021/OL061651O
Xuesong Liu, Yan Shi, Vincent L. Giranda, Yan Luo, Inhibition of the phosphatidylinositol 3-kinase/Akt pathway sensitizes MDA-MB468 human breast cancer cells to cerulenin-induced apoptosis Molecular Cancer Therapeutics. ,vol. 5, pp. 494- 501 ,(2006) , 10.1158/1535-7163.MCT-05-0049
Richard Flavin, Giorgia Zadra, Massimo Loda, Metabolic alterations and targeted therapies in prostate cancer. The Journal of Pathology. ,vol. 223, pp. 283- 294 ,(2011) , 10.1002/PATH.2809
Reema S. Wahdan-Alaswad, Dawn R. Cochrane, Nicole S. Spoelstra, Erin N. Howe, Susan M. Edgerton, Steven M. Anderson, Ann D. Thor, Jennifer K. Richer, Metformin-Induced Killing of Triple Negative Breast Cancer Cells is Mediated by Reduction in Fatty Acid Synthase via miRNA-193b Hormones and Cancer. ,vol. 5, pp. 374- 389 ,(2014) , 10.1007/S12672-014-0188-8
Alejandro Vazquez-Martin, Bruna Corominas-Faja, Sílvia Cufi, Luciano Vellon, Cristina Oliveras-Ferraros, Octavio J. Menendez, Jorge Joven, Ruth Lupu, Javier A. Menendez, The mitochondrial H(+)-ATP synthase and the lipogenic switch: new core components of metabolic reprogramming in induced pluripotent stem (iPS) cells. Cell Cycle. ,vol. 12, pp. 207- 218 ,(2013) , 10.4161/CC.23352
Piero L. Alò, Paolo Visca, Claudio Botti, Gregorio M. Galati, Valeria Sebastiani, Tiziana Andreano, Ugo Di Tondo, Ellen S. Pizer, Immunohistochemical expression of human erythrocyte glucose transporter and fatty acid synthase in infiltrating breast carcinomas and adjacent typical/atypical hyperplastic or normal breast tissue American Journal of Clinical Pathology. ,vol. 116, pp. 129- 134 ,(2001) , 10.1309/5Y2L-CDCK-YB55-KDK6
Alan R. RENDINA, Dong CHENG, Characterization of the inactivation of rat fatty acid synthase by C75: inhibition of partial reactions and protection by substrates. Biochemical Journal. ,vol. 388, pp. 895- 903 ,(2005) , 10.1042/BJ20041963
Jill M. McFadden, Susan M. Medghalchi, Jagan N. Thupari, Michael L. Pinn, Aravinda Vadlamudi, Katherine I. Miller, Francis P. Kuhajda, Craig A. Townsend, Application of a flexible synthesis of (5R)-thiolactomycin to develop new inhibitors of type I fatty acid synthase. Journal of Medicinal Chemistry. ,vol. 48, pp. 946- 961 ,(2005) , 10.1021/JM049389H
PR Pandey, F Xing, S Sharma, M Watabe, SK Pai, M Iiizumi-Gairani, K Fukuda, S Hirota, YY Mo, K Watabe, None, Elevated lipogenesis in epithelial stem-like cell confers survival advantage in ductal carcinoma in situ of breast cancer. Oncogene. ,vol. 32, pp. 5111- 5122 ,(2013) , 10.1038/ONC.2012.519
J. A. Menendez, L. Vellon, I. Mehmi, B. P. Oza, S. Ropero, R. Colomer, R. Lupu, Inhibition of fatty acid synthase (FAS) suppresses HER2/neu (erbB-2) oncogene overexpression in cancer cells. Proceedings of the National Academy of Sciences of the United States of America. ,vol. 101, pp. 10715- 10720 ,(2004) , 10.1073/PNAS.0403390101